THLD OPTR NBS CNDO MEIP - Investor Relations Responses Posted

Another new set of investor relations (IR) questions and responses from biotechs provided by Mike O'Neill has been posted, covering financials and upcoming catalysts for each biotech stock. 

This round of responses features Threshold Pharmaceuticals THLD, Optimer Pharmaceuticals OPTR, Neostem Inc NBS, Coronado Biosciences CNDO, and MEI Pharma MEIP.

Check out the complete index of all IR Questions and Answers if you missed the previous editions (covering >50 biotech and pharmaceutical companies)